Live from the NIH registry
Studies recruiting near Richmond right now
Top 25 of 622 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
VCU — Richmond, Virginia (1.9 mi)
· Sponsor: AskBio Inc
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Giselle Sholler
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
VCU Massey Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Virginia Cancer Center — Richmond, Virginia (1.9 mi)
· Sponsor: Dosentrx Ltd.
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Richmond, Virginia (1.9 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Bon Secours Cancer Institute at St. Francis ( Site 0048) — Midlothian, Virginia (9.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Bon Secours Cancer Institute at St. Mary's Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: Pfizer
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension, Interstitial Lung Disease
Phase 3
Interventional 344 participants sought
USA008 — Richmond, Virginia (1.9 mi)
· Sponsor: Insmed Incorporated
Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts
Treatment Adherence
N/A
Interventional 350 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Heart Failure, Congestive, Death, Sudden, Cardiac
N/A
Observational 1,500 participants sought
Virginia Commonwealth University School of Medicine — Richmond, Virginia (1.9 mi)
· Sponsor: Johns Hopkins University
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Institute of Virginia — Richmond, Virginia (1.9 mi)
· Sponsor: Genentech, Inc.
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Congenital Myotonic Dystrophy, CDM
N/A
Observational 50 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigational Site — Richmond, Virginia (1.9 mi)
· Sponsor: Alkermes, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Bon Secours Saint Mary's Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: NRG Oncology
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
Motor Adaptation and Generalization, Posterior Parietal Cortex
N/A
Interventional 60 participants sought
Virginia Commonwealth University Medical Center — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Richmond, Virginia (1.9 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Bon Secours Richmond Community Hospital — Richmond, Virginia (1.9 mi)
· Sponsor: NRG Oncology
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging
N/A
Interventional 1,000 participants sought
Virginia Commonwealth University — Richmond, Virginia (1.9 mi)
· Sponsor: Brigham and Women's Hospital
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Opioid Use Disorder, Opioid Use
Phase 2
Interventional 100 participants sought
VCU Institute for Drug and Alcohol Studies — Richmond, Virginia (1.9 mi)
· Sponsor: Virginia Commonwealth University
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Virginia Commonwealth University - Massey — Richmond, Virginia (1.9 mi)
· Sponsor: NSABP Foundation Inc
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0337 — Richmond, Virginia (1.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Clinical Research Partners, LLC — Richmond, Virginia (1.9 mi)
· Sponsor: Eli Lilly and Company
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Hunter Holmes McGuire VA Medical Center, Richmond, VA — Richmond, Virginia (1.9 mi)
· Sponsor: VA Office of Research and Development